Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20028 | 26200028 | Rev Esp Quimioter | Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients. | 2015 | Details |
| A20045 | 26193051 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease-related cardiovascular risk: Is there an association with blood hemoglobin levels? | 2015 | Details |
| A20050 | 26190559 | Food Funct | Modulation of tissue fatty acids by L-carnitine attenuates metabolic syndrome in diet-induced obese rats. | 2015 | Details |
| A20061 | 26185598 | World J Diabetes | Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome. | 2015 | Details |
| A20068 | 26179110 | Hepatol Res | Association of non-alcoholic fatty liver disease with impaired endothelial function by flow-mediated dilation: A meta-analysis. | 2015 | Details |
| A20094 | 26159280 | Dig Dis | Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH. | 2015 | Details |
| A20099 | 26155623 | Ter Arkh | [Evaluation of endothelial function and estimation of the degree of apoptosis in patients with metabolic syndrome and non-alcoholic fatty liver disease]. | 2015 | Details |
| A20102 | 26154274 | Menopause | Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women. | 2015 | Details |
| A20114 | 26147308 | Clin Transplant | Non-alcoholic fatty liver disease following liver transplantation: a clinical review. | 2015 | Details |
| A20146 | 26124760 | Front Immunol | Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies. | 2015 | Details |
| A20156 | 26118770 | Recent Pat Food Nutr Agric | Soybean and Processed Soy Foods Ingredients, and Their Role in Cardiometabolic Risk Prevention. | 2015 | Details |
| A20157 | 26117210 | Vascul Pharmacol | Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome. | 2015 | Details |
| A20170 | 26113868 | Evid Based Complement Alternat Med | Effects on Liver Lipid Metabolism of the Naturally Occurring Dietary Flavone Luteolin-7-glucoside. | 2015 | Details |
| A20186 | 26098879 | PLoS One | Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet. | 2015 | Details |
| A20196 | 26090409 | Biomed Res Int | Developmental Programming of Nonalcoholic Fatty Liver Disease: The Effect of Early Life Nutrition on Susceptibility and Disease Severity in Later Life. | 2015 | Details |
| A20197 | 26090093 | J Nutr Sci | Assessment of cardiometabolic risk in children in population studies: underpinning developmental origins of health and disease mother-offspring cohort studies. | 2015 | Details |
| A20203 | 26085908 | World J Hepatol | "Weighing the risk": Obesity and outcomes following liver transplantation. | 2015 | Details |
| A20221 | 26078558 | World J Gastroenterol | Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. | 2015 | Details |
| A20229 | 26076562 | Rom J Intern Med | Noninvasive Markers of Improvement of Liver Steatosis Achieved by Weight Reduction in Patients with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20230 | 26076555 | Rom J Intern Med | Chronic Kidney Disease--Chronic Liver Disease. An Immunologic Cross-talk. | 2015 | Details |
| A20236 | 26071652 | PM R | Perception of Effort During Activity in Patients With Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20237 | 26070860 | Expert Rev Gastroenterol Hepatol | Physiology and pathophysiology of liver lipid metabolism. | 2015 | Details |
| A20239 | 26070222 | Am J Cardiol | Relation of Anthropometric Obesity and Computed Tomography Measured Nonalcoholic Fatty Liver Disease (from the Multiethnic Study of Atherosclerosis). | 2015 | Details |
| A20262 | 26057287 | JAMA | Nonalcoholic fatty liver disease: a systematic review. | 2015 | Details |
| A20270 | 26052382 | World J Hepatol | Non-alcoholic fatty liver disease - the heart of the matter. | 2015 | Details |
| A20271 | 26052378 | World J Hepatol | Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis. | 2015 | Details |
| A20278 | 26049073 | Semin Thromb Hemost | Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20282 | 26046667 | Eur J Clin Invest | Alanine aminotransferase and mortality in patients with type 2 diabetes (ZODIAC-38). | 2015 | Details |
| A20283 | 26046396 | Nutrients | Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) Is a Novel Nutritional Therapeutic Target for Hyperlipidemia, Non-Alcoholic Fatty Liver Disease, and Atherosclerosis. | 2015 | Details |
| A20293 | 26042596 | PLoS One | Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes. | 2015 | Details |
| A20301 | 26039828 | Arq Gastroenterol | Nonalcoholic fatty liver disease in patients with coronary disease from a Brazil northeast area. | 2016 | Details |
| A20331 | 26026214 | Nutr Metab Cardiovasc Dis | A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease. | 2015 | Details |
| A20335 | 26024975 | Endocrine | Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis? | 2015 | Details |
| A20337 | 26024397 | Rocz Panstw Zakl Hig | Health effects of changes in the structure of dietary macronutrients intake in western societies. | 2015 | Details |
| A20341 | 26021488 | Diabetologia | Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial. | 2015 | Details |
| A20345 | 26019740 | World J Hepatol | Valproic acid and nonalcoholic fatty liver disease: A possible association? | 2015 | Details |
| A20359 | 26017459 | Pediatr Blood Cancer | Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation. | 2015 | Details |
| A20367 | 26011302 | Metab Syndr Relat Disord | Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20372 | 26005677 | Hepatobiliary Surg Nutr | Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. | 2015 | Details |
| A20397 | 25993337 | PLoS One | Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis. | 2015 | Details |
| A20398 | 25993066 | Einstein (Sao Paulo) | Physical activity as a protective factor for development of non-alcoholic fatty liver in men. | 2015 | Details |
| A20406 | 25988358 | Atherosclerosis | Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease. | 2015 | Details |
| A20410 | 25986611 | Cardiovasc Diabetol | Sex influenced association of directly measured insulin sensitivity and serum transaminase levels: Why alanine aminotransferase only predicts cardiovascular risk in men? | 2015 | Details |
| A20411 | 25984978 | J Clin Gastroenterol | Nonalcoholic Fatty Liver Disease and Mean Platelet Volume: A Systemic Review and Meta-analysis. | 2016 | Details |
| A20418 | 25979856 | Eur J Pharmacol | An experimental study on amelioration of dyslipidemia-induced atherosclesis by Clematichinenoside through regulating Peroxisome proliferator-activated receptor-α mediated apolipoprotein A-I, A-II and C-III. | 2015 | Details |
| A20419 | 25977117 | Liver Int | Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis. | 2015 | Details |
| A20423 | 25974699 | Annu Rev Nutr | Health Benefits of Long-Term Weight-Loss Maintenance. | 2015 | Details |
| A20430 | 25972092 | Biol Pharm Bull | Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice. | 2015 | Details |
| A20444 | 25960049 | Obesity (Silver Spring) | Nonalcoholic fatty liver disease and cardiovascular risk in children with obesity. | 2015 | Details |
| A20448 | 25957758 | Metabolism | Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. | 2015 | Details |
| A20468 | 25941433 | J Clin Exp Hepatol | Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. | 2015 | Details |
| A20492 | 25925168 | Lipids Health Dis | Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents. | 2015 | Details |
| A20502 | 25920090 | J Hepatol | NAFLD: a multisystem disease. | 2015 | Details |
| A20516 | 25914296 | Hepatology | Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study. | 2015 | Details |
| A20547 | 25894944 | Curr Diab Rep | Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms. | 2015 | Details |
| A20549 | 25893821 | Pediatr Obes | TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children. | 2015 | Details |
| A20573 | 25876863 | Zhonghua Liu Xing Bing Xue Za Zhi | [Relationship between ideal cardiovascular behaviors/factors and the prevalence of nonalcoholic fatty liver disease]. | 2015 | Details |
| A20576 | 25875942 | PLoS One | LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD). | 2015 | Details |
| A20577 | 25875390 | Atherosclerosis | Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men. | 2015 | Details |
| A20579 | 25875119 | Nutrients | A green algae mixture of Scenedesmus and Schroederiella attenuates obesity-linked metabolic syndrome in rats. | 2015 | Details |
| A20581 | 25873773 | Mediators Inflamm | OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease. | 2015 | Details |
| A20593 | 25866601 | World J Hepatol | Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease. | 2015 | Details |
| A20608 | 25853894 | Horm Metab Res | A Nonclassical Monocyte Phenotype in Peripheral Blood is Associated with Nonalcoholic Fatty Liver Disease: A Report from an EMIL Subcohort. | 2015 | Details |
| A20618 | 25849783 | Cardiovasc Diabetol | Cardiac structure and function are altered in type 2 diabetes and non-alcoholic fatty liver disease and associate with glycemic control. | 2015 | Details |
| A20642 | 25838034 | Metabolism | Endoplasmic Reticulum Stress Response in Non-alcoholic Steatohepatitis: The Possible Role of Physical Exercise. | 2015 | Details |
| A20651 | 25832152 | Med J Aust | The imperative to prevent diabetes complications: a broadening spectrum and an increasing burden despite improved outcomes. | 2015 | Details |
| A20653 | 25830307 | Ann Gastroenterol | Metabolic and cardiovascular complications in the liver transplant recipient. | 2020 | Details |
| A20657 | 25825591 | Hepat Mon | Association of Tumor Necrosis Factor-alpha Polymorphisms and Risk of Coronary Artery Disease in Patients With Non-alcoholic Fatty Liver Disease. | 2015 | Details |
| A20658 | 25824073 | Clin Med (Lond) | Non-alcoholic fatty liver disease: when to intervene and with what. | 2015 | Details |
| A20660 | 28511747 | Acta Dermatovenerol Croat | Red Blood Cell Distribution Width is a Reliable Marker of Inflammation in Plaque Psoriasis. | 2017 | Details |
| A20667 | 25818101 | Angiology | Epicardial Fat in Nonalcoholic Fatty Liver Disease: Properties and Relationships With Metabolic Factors, Cardiac Structure, and Cardiac Function. | 2015 | Details |
| A20671 | 25816034 | Medicine (Baltimore) | Nonalcoholic fatty liver disease as a risk factor of arterial stiffness measured by the cardioankle vascular index. | 2015 | Details |
| A20674 | 25810989 | J Family Med Prim Care | Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians? | 2015 | Details |
| A20685 | 25799683 | Arch Latinoam Nutr | [Prevalence of no alcohol fatty liver disease (NAFLD) in a population of obese children in Valencia, Venezuela]. | 2014 | Details |
| A20695 | 25795939 | Nutr Hosp | Cut-off values of waist circumference to predict metabolic syndrome in obese adolescents. | 2015 | Details |
| A20697 | 25794039 | J Am Coll Nutr | Consumption of Oxidized and Partially Hydrogenated Oils Differentially Induces Trans-Fatty Acids Incorporation in Rats' Heart and Dyslipidemia. | 2015 | Details |
| A20704 | 25788761 | Mediators Inflamm | Presence of fatty liver and the relationship between alcohol consumption and markers of inflammation. | 2015 | Details |
| A20709 | 25788195 | Hepatol Int | Association between retinal artery lesions and nonalcoholic fatty liver disease. | 2015 | Details |
| A20719 | 25776891 | J Hepatol | Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study. | 2015 | Details |
| A20721 | 25776455 | Am J Cardiol | Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors. | 2015 | Details |
| A20725 | 25774664 | Child Obes | Differences in Cardiometabolic Risk between Insulin-Sensitive and Insulin-Resistant Overweight and Obese Children. | 2015 | Details |
| A20726 | 25774446 | Curr Opin Gastroenterol | Nonalcoholic fatty liver disease: new treatments. | 2015 | Details |
| A20731 | 25772181 | Endocr Metab Immune Disord Drug Targets | Adiponectin as a Target in Obesity-related Inflammatory State. | 2015 | Details |
| A20758 | 25753407 | Obes Rev | Paediatric non-alcoholic fatty liver disease: an overview. | 2015 | Details |
| A20769 | 25745056 | Arterioscler Thromb Vasc Biol | Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study. | 2015 | Details |
| A20783 | 25736377 | EMBO J | Interrupting synoviolin play at the ER: a plausible action to elevate mitochondrial energetics and silence obesity. | 2015 | Details |
| A20796 | 25729707 | Diabetes Metab J | Hepatokines as a Link between Obesity and Cardiovascular Diseases. | 2015 | Details |
| A20819 | 25714579 | J Pediatr Gastroenterol Nutr | Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. | 2015 | Details |
| A20841 | 25697114 | Med Hypotheses | Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH. | 2015 | Details |
| A20842 | 25694178 | Expert Rev Gastroenterol Hepatol | Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications. | 2015 | Details |
| A20845 | 25690590 | Curr Atheroscler Rep | FXR agonists as therapeutic agents for non-alcoholic fatty liver disease. | 2015 | Details |
| A20846 | 25690560 | Eur J Clin Invest | Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders. | 2015 | Details |
| A20847 | 25690422 | Nutrients | Low-normal thyroid function and novel cardiometabolic biomarkers. | 2015 | Details |
| A20849 | 25688578 | Hemodial Int | Relationship between non-alcoholic fatty liver disease and MIA syndrome. | 2015 | Details |
| A20889 | 25661453 | Clin Gastroenterol Hepatol | Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20890 | 25659874 | Atheroscler Suppl | The effect of ezetimibe on NAFLD. | 2015 | Details |
| A20899 | 25655252 | Postgrad Med J | Republished: Non-alcoholic fatty liver disease: a practical approach to treatment. | 2015 | Details |
| A20905 | 25654080 | Front Med (Lausanne) | Management of moderate to severe psoriasis in patients with metabolic comorbidities. | 2015 | Details |
| A20910 | 25648511 | Mar Drugs | Seaweed supplements normalise metabolic, cardiovascular and liver responses in high-carbohydrate, high-fat fed rats. | 2015 | Details |
| A20923 | 25643676 | Gac Med Mex | [Dietary patterns and physical activity in the mexican population: association with fatty liver]. | 2014 | Details |